HBD-2 mutations are associated with childhood asthma and prophylactic hBD-2 application prevents asthma in mice

N. Borchers (Regensburg, Germany), E. Santos-Valente (Regensburg, Germany), A. Toncheva (Regensburg, Germany), J. Wehkamp (Tübingen, Germany), A. Franke (Kiel, Germany), V. Gaertner (Regensburg, Germany), P. Nordkild (Copenhagen, Denmark), J. Genuneit (Leipzig, Germany), B. Jensen (Copenhagen, Denmark), M. Kabesch (Regensburg, Germany)

Source: Virtual Congress 2021 – Paediatric lung disease: novel mechanisms, methods and translational studies
Session: Paediatric lung disease: novel mechanisms, methods and translational studies
Session type: Oral Presentation
Number: 1620

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Borchers (Regensburg, Germany), E. Santos-Valente (Regensburg, Germany), A. Toncheva (Regensburg, Germany), J. Wehkamp (Tübingen, Germany), A. Franke (Kiel, Germany), V. Gaertner (Regensburg, Germany), P. Nordkild (Copenhagen, Denmark), J. Genuneit (Leipzig, Germany), B. Jensen (Copenhagen, Denmark), M. Kabesch (Regensburg, Germany). HBD-2 mutations are associated with childhood asthma and prophylactic hBD-2 application prevents asthma in mice. 1620

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Upregulation of interleukin-19 in severe asthma: a potential saliva biomarker for asthma severity
Source: ERJ Open Res, 7 (3) 00984-2020; 10.1183/23120541.00984-2020
Year: 2021



MMP-9 gene variants increase the risk for non-atopic asthma in children
Source: Annual Congress 2010 - Phenotypes, mechanisms and diagnosis of asthma in childhood
Year: 2010

The impact of targeted therapy in children with uncontrolled allergic persistent severe asthma and nasal polyps
Source: International Congress 2017 – Paediatric asthma: therapies and comorbidities
Year: 2017

Caspase-1 deficiency reduces eosinophilia and interleukin-33 in an asthma exacerbation model
Source: ERJ Open Res, 3 (4) 00047-2017; 10.1183/23120541.00047-2017
Year: 2017



The effects of IL12B promoter polymorphism on co-existence of allergic rhinitis or familial asthma history, serum total IgE and eosinophil level in asthma patients
Source: Annual Congress 2008 - Advances in functional genomics of neoplastic and non-neoplastic lung diseases
Year: 2008


MUC5AC expression decrease correlates with the decline in rates of severe asthma exacerbations post bronchial thermoplasty
Source: International Congress 2017 – Novel mechanisms and treatments for asthma
Year: 2017

Omalizumab therapy reduces asthma exacerbations in children with severe allergic (IgE-mediated) asthma irrespective of lung function at baseline
Source: Annual Congress 2009 - Difficult asthma in children: diagnostic and therapeutic challenges
Year: 2009

Decreased Smad7 expression in the airways of a mouse model of chronic asthma
Source: Annual Congress 2004 - Animal models of allergic airway disease
Year: 2004


Rhinovirus infection in young children is associated with elevated airway TSLP levels
Source: Eur Respir J 2014; 44: 1075-1078
Year: 2014


HDAC6 inhibition and deletion reduce COPD symptoms in mice and human airway epithelia
Source: Virtual Congress 2020 – Elucidating the mechanisms underlying lung repair and exploring therapeutic strategies in vitro
Year: 2020




IL-33 mRNA in induced sputum cells from allergic rhinitis and asthma patients: a marker of Th-2 phenotype status?
Source: International Congress 2017 – Monitoring asthma control
Year: 2017

High-level expression of PD-L1 by DC suppresses airway inflammation in OVA-induced allergic asthma
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010

DPP10 protein expression is associated with the pathogenesis of asthma and COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 231s
Year: 2005

Asthma in combination with rhinitis and eczema is associated with higher levels of type-2 inflammation and symptom burden
Source: Virtual Congress 2021 – Biomarkers and risk factors in childhood asthma
Year: 2021


IL-33 and airway remodelling in paediatric severe therapy resistant asthma
Source: Annual Congress 2012 - Severe asthma and developing allergy in childhood
Year: 2012

MMP-9 deficiency reduces airway inflammation and hyperresponsiveness in a mouse model of asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 20s
Year: 2001

Overexpression of eNOS suppresses asthmatic features in a mouse model of allergic asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 28s
Year: 2002

Expression of MMP-8 protein in alveolar macrophages is related to bronchial asthma severity and treatment efficacy
Source: Annual Congress 2010 - Cell biology and immunology of lung disease
Year: 2010

Arg/Gly polymorphism of β2-adrenoreceptor gene is associated with respiratory infections in early life and increased IgE level in asthmatic children
Source: Eur Respir J 2005; 26: Suppl. 49, 400s
Year: 2005

Increased levels of IL-31 mRNA is in cough variant asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 374s
Year: 2007